17:I[66739,["/_next/static/chunks/0.3dg.jzl0xwf.js?dpl=dpl_HxkEdW1svcQjgbrN1tU7t1UmY5CX","/_next/static/chunks/05hx6kuf6-oy4.js?dpl=dpl_HxkEdW1svcQjgbrN1tU7t1UmY5CX","/_next/static/chunks/0~heydqc5smtk.js?dpl=dpl_HxkEdW1svcQjgbrN1tU7t1UmY5CX","/_next/static/chunks/0juapqyy99ga..js?dpl=dpl_HxkEdW1svcQjgbrN1tU7t1UmY5CX","/_next/static/chunks/0mb4-6jpfhd0o.js?dpl=dpl_HxkEdW1svcQjgbrN1tU7t1UmY5CX","/_next/static/chunks/06dn~uer6.43l.js?dpl=dpl_HxkEdW1svcQjgbrN1tU7t1UmY5CX"],"default"] 19:I[38632,["/_next/static/chunks/0qqtp3r0h7kah.js?dpl=dpl_HxkEdW1svcQjgbrN1tU7t1UmY5CX","/_next/static/chunks/0iukvycbd42rl.js?dpl=dpl_HxkEdW1svcQjgbrN1tU7t1UmY5CX"],"IconMark"] 18:T550,

Ashley Cordova, CEO of Novocure (NVCR), joins Trading 360 after ringing the opening bell at the Nasdaq. Novocure “targets the electrical properties of cells” to fight aggressive cancers. “We are focused on extending survival,” she says, and notes recent FDA approval for lung cancer treatment and clinical trials in pancreatic and brain cancers. She also discusses the company’s balance sheet, R&D investment, and potential partnerships.

======== Schwab Network ========

Empowering every investor and trader, every market day.

Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribe

Download the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185

Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7

Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watch

Watch on Vizio - https://www.vizio.com/en/watchfreeplus-explore

Watch on DistroTV - https://www.distro.tv/live/schwab-network/

About Schwab Network - https://schwabnetwork.com/about

Novocure CEO on Fighting Aggressive Cancers, Treatment Development Pipeline

Schwab Network

Novocure CEO on Fighting Aggressive Cancers, Treatment Development Pipeline